Fibula Free Flap With Endosseous Implants for Reconstructing a Resected Mandible in Bisphosphonate Osteonecrosis

Journal of Oral and Maxillofacial Surgery

Volumn 66, Issue 5, 2008, Pages 999-1003

  Ferrari, Silvano ^a   Bianchi, Bernardo ^a   Savi, Andrea ^a   Poli, Tito ^a   Multinu, Alessandra ^a   Balestreri, Alfredo ^a   Ferri, Andrea ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; GENTAMICIN; MEROPENEM; PAMIDRONIC ACID; ZOLEDRONIC ACID;

AGED; ARTICLE; BONE NECROSIS; CASE REPORT; ESTHETIC SURGERY; FIBULA GRAFT; FISTULA; FOLLOW UP; FREE TISSUE GRAFT; HUMAN; IMPLANT; JAW DISEASE; MALE; MANDIBLE FRACTURE; MANDIBLE RECONSTRUCTION; MANDIBLE RESECTION; MULTIPLE MYELOMA; TREATMENT OUTCOME;

AGED; BONE DENSITY CONSERVATION AGENTS; BONE TRANSPLANTATION; DENTAL IMPLANTATION, ENDOSSEOUS; DIPHOSPHONATES; FIBULA; HUMANS; MALE; MANDIBLE; MANDIBULAR DISEASES; MANDIBULAR FRACTURES; ORAL SURGICAL PROCEDURES, PREPROSTHETIC; OSTEONECROSIS; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL FLAPS;

EID: 41949132378     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2007.06.631     Document Type: Article

References (16)

1. Marx R.E. Pamidronate- (Aredia) and zoledronate- (Zometa) induced avascular necrosis of the jaws: A growing epidemic. [letter]. J Oral Maxillofac Surg 61 (2003) 115
2. Luckman S.P., Hughes D.E., Coxon F.P., et al. Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: Evidence from structure-activity relationships in J774 macrophages. J Bone Miner Res 13 (1998) 1668
3. Ashcroft A.J., Davies F.E., and Morgan G.J. Aetiology of bone disease and the role of bisphosphonates in multiple myeloma. Lancet Oncol 4 (2003) 284
4. Djulbegovic B., Whetley K., Ross J., et al. Bisphosphonates in multiple myeloma (Cochrane Review). Cochrane Database Syst Rev 3 (2002) CD003188
5. Assael L.A. New foundation in understanding osteonecrosis of the jaws. J Oral Maxillofac Surg 62 (2004) 125
6. Lugassy G., Shaham R., Nemets A., et al. Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: A new clinical entity. Am J Med 117 (2004) 440
7. Greenberg M.S. Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 259
8. Abu-Id M.H., Acil Y., Gottschalk J., et al. Bisphosphonate-associated osteonecrosis of the jaw. Mund Kiefer Gesichtschir 10 (2006) 73
9. Badros A., Weikel D., Salama A., et al. Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors. J Clin Oncol 24 (2006) 945
10. Carter G.D., and Goss A.N. Bisphosphonates and avascular necrosis of the jaws. [letter]. Australian Prescriber 27 (2004) 32
11. Adverse Drug Reactions Advisory Committee (ADRAC). Bisphosphonates and osteonecrosis of the jaw. Aust Adv Drug Reactions Bull 24 (2005) 3 1
12. Schwartz H.C. Osteonecrosis and bisphosphonates: Correlation versus caution. J Oral Maxillofac Surg 62 (2004) 763
13. Wang J., Goodger N.M., and Pogrel M.A. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61 (2003) 1104
14. Migliorati C.A. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21 (2003) 4253
15. Pogrel M.A. Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 62 (2004) 391
16. Ruggiero S., and Rosenberg T.J. Osteonecrosis of the jaws associated with the use of bisphosphonates. J Oral Maxillofac Surg 62 (2004) 527